346 related articles for article (PubMed ID: 12032108)
21. Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.
Barnett AH; Burger J; Johns D; Brodows R; Kendall DM; Roberts A; Trautmann ME
Clin Ther; 2007 Nov; 29(11):2333-48. PubMed ID: 18158075
[TBL] [Abstract][Full Text] [Related]
22. Frequency of glycated hemoglobin monitoring was inversely associated with glycemic control of patients with Type 2 diabetes mellitus.
Fu C; Ji L; Wang W; Luan R; Chen W; Zhan S; Xu B
J Endocrinol Invest; 2012 Mar; 35(3):269-73. PubMed ID: 21606668
[TBL] [Abstract][Full Text] [Related]
23. Comorbidity and glycemic control in patients with type 2 diabetes.
El-Kebbi IM; Ziemer DC; Cook CB; Miller CD; Gallina DL; Phillips LS
Arch Intern Med; 2001 May; 161(10):1295-300. PubMed ID: 11371257
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
Luis Bautista J; Bugos C; Dirnberger G; Atherton T
Clin Ther; 2003 Jan; 25(1):194-209. PubMed ID: 12637120
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
Herz M; Johns D; Reviriego J; Grossman LD; Godin C; Duran S; Hawkins F; Lochnan H; Escobar-Jiménez F; Hardin PA; Konkoy CS; Tan MH
Clin Ther; 2003 Apr; 25(4):1074-95. PubMed ID: 12809958
[TBL] [Abstract][Full Text] [Related]
26. A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in African American and Hispanic American patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy.
Davidson JA; McMorn SO; Waterhouse BR; Cobitz AR
Clin Ther; 2007 Sep; 29(9):1900-14. PubMed ID: 18035190
[TBL] [Abstract][Full Text] [Related]
27. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
Harris MI;
Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
[TBL] [Abstract][Full Text] [Related]
28. Racial differences in glycemic control in a well-functioning older diabetic population: findings from the Health, Aging and Body Composition Study.
de Rekeneire N; Rooks RN; Simonsick EM; Shorr RI; Kuller LH; Schwartz AV; Harris TB;
Diabetes Care; 2003 Jul; 26(7):1986-92. PubMed ID: 12832300
[TBL] [Abstract][Full Text] [Related]
29. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
30. Peer mentoring and financial incentives to improve glucose control in African American veterans: a randomized trial.
Long JA; Jahnle EC; Richardson DM; Loewenstein G; Volpp KG
Ann Intern Med; 2012 Mar; 156(6):416-24. PubMed ID: 22431674
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.
Moretto TJ; Milton DR; Ridge TD; Macconell LA; Okerson T; Wolka AM; Brodows RG
Clin Ther; 2008 Aug; 30(8):1448-60. PubMed ID: 18803987
[TBL] [Abstract][Full Text] [Related]
32. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
[TBL] [Abstract][Full Text] [Related]
33. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.
Petitti DB; Klingensmith GJ; Bell RA; Andrews JS; Dabelea D; Imperatore G; Marcovina S; Pihoker C; Standiford D; Waitzfelder B; Mayer-Davis E;
J Pediatr; 2009 Nov; 155(5):668-72.e1-3. PubMed ID: 19643434
[TBL] [Abstract][Full Text] [Related]
34. The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.
Erdman DM; Cook CB; Greenlund KJ; Giles WH; El-Kebbi I; Ryan GJ; Gallina DL; Ziemer DC; Dunbar VG; Phillips LS
Diabetes Care; 2002 Jan; 25(1):9-15. PubMed ID: 11772894
[TBL] [Abstract][Full Text] [Related]
35. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis.
Shenolikar RA; Balkrishnan R; Camacho FT; Whitmire JT; Anderson RT
Clin Ther; 2006 Aug; 28(8):1199-1207. PubMed ID: 16982297
[TBL] [Abstract][Full Text] [Related]
36. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
37. The relationship between self-monitored blood glucose values and glycated haemoglobin in insulin-treated patients with Type 2 diabetes.
Sarwat S; Ilag LL; Carey MA; Shrom DS; Heine RJ
Diabet Med; 2010 May; 27(5):589-92. PubMed ID: 20536957
[TBL] [Abstract][Full Text] [Related]
38. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
Blonde L; Merilainen M; Karwe V; Raskin P;
Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
[TBL] [Abstract][Full Text] [Related]
39. Drug titration patterns and HbA 1c levels in type 2 diabetes.
Maclean JR; Chapman RH; Ferrufino CP; Krishnarajah G
Int J Clin Pract; 2009 Jul; 63(7):1008-16. PubMed ID: 19570118
[TBL] [Abstract][Full Text] [Related]
40. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
Currie CJ; Peters JR; Tynan A; Evans M; Heine RJ; Bracco OL; Zagar T; Poole CD
Lancet; 2010 Feb; 375(9713):481-9. PubMed ID: 20110121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
